Thirona continues to build upon its decade-long commitment to driving innovation in AI-powered lung image analysis. Our mission remains steadfast: to advance personalized care for patients with respiratory diseases — from clinical trials to real-world hospital settings. To do so, we collaborate with leading medical experts who bring their experience, vision, and the patient’s voice into the heart of our development.

Today, we are proud to announce the expansion of our Medical Advisory Board with the addition of three world-renowned pulmonologists, each recognized for their pioneering work in the diagnosis and treatment of complex respiratory conditions: Dr. Eva Polverino, (Hospital Vall d’Hebron, Spain), Prof. Arnaud Bourdin (University of Montpellier, France) and Prof. Patrick Flume (Medical University of South Carolina, USA).

With their decades of expertise in clinical care and translational research, our new board members bring valuable perspectives on how AI can address the unmet needs in respiratory disease management — from early diagnosis and phenotyping to long-term monitoring.

By working together with these esteemed clinicians, Thirona continues to strengthen the scientific and clinical foundation of our solutions, helping ensure that advanced AI technologies make a tangible, positive difference in the lives of patients worldwide.

We warmly welcome them to Thirona’s international network of lung disease experts.